Prof. Kyselovič Ján, Pharm.D., CSc.
Research/art/teacher profile
Date of last update: 22.10.2026
I. Basic information
| I.1 Surname |
Kyselovič |
|---|---|
| I.2 Given name |
Ján |
| I.3 Degrees |
Prof. , Pharm.D., CSc. |
| I.4 Year of birth |
1963 |
| I.5 Name of the workplace |
University of Veterinary Medicine and Pharmacy in Košice, Department of Pharmacology and Toxicology |
| I.6 Address of the workplace |
Komenského 73, 041 81 Košice, Slovak Republic |
| I.7 Position |
professor |
| I.8 E-mail address | jan.kyselovic@uvlf.sk |
| I.9 University staff register / partner university profile | https://www.portalvs.sk/regzam/detail/3738 |
| I.11 ORCID iD | 0000-0001-9208-5352 |
II. Higher education and further qualification growth
| Institution | Year | Study field and programme | |
|---|---|---|---|
| Second degree higher education | Comenius University in Bratislava, Faculty of Pharmacy | 1987 | clinical pharmacy |
| Third degree higher education | Commenius University in Bratislava, Faculty of Medicine | 1993 | pharmacology |
| Habilitation procedure | Comenius University in Bratislava, Faculty of Pharmacy | 2003 | pharmacology |
| Inaugural procedure | Comenius University in Bratislava, Faculty of Pharmacy | 2009 | pharmacology |
III. Current and previous employment
| Occupation | Institution | Year |
|---|---|---|
professor | University of veterinary medicine and pharmacy in Košice | 2021 – to date |
head of clinical research unit | Faculty of Medicine, Commenius University, Bratislava | 2017 – to date |
assistant | University of veterinary medicine and pharmacy in Košice | 2014 – 2021 |
professor | Faculty of Medicine, Commenius University, Bratislava | 2013 – 2015 |
professor | Faculty of Pharmacy, Comenius University in Bratislava | 2009 – 2017 |
assotiate professor | Faculty of Pharmacy, Comenius University in Bratislava | 2003 – 2009 |
assistant | Faculty of Pharmacy, Comenius University in Bratislava | 1992 – 2003 |
IV. Development of pedagogical, professional, language, digital and other skills
| Activity | Institution | Year |
|---|---|---|
visiting scientist | Research unit, Sainte Justine nemocnica, Montreal, Canada | 2004 |
visiting scientist | Department of Pharmacology and Toxicology, UCL Brussels, Belgium | 1996 |
postgradual study stay MDAC in Pharmacology | Medical Faculty, Department Pharmacology, University of Ottawa, Canada | 1993 |
study stay - grant MRC of Canada | Medical Faculty, Department Pharmacology, University of Ottawa, Canada | 1992 |
V. Overview of activities within the teaching career at the university
Academic year: 2026/2027
V.1. Overview of taught profile courses
| Profile course | Study programme | Degree | Study field |
|---|---|---|---|
Pharmacology | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Pharmacology I. | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Pharmacology | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Pharmacology II. | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Clinical pharmacology and pharmacotherapy | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Clinical pharmacology and pharmacotherapy | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Pharmacology II. | Pharmacy – full-time study, Slovak language | I. + II. | Pharmacy |
V.2. Responsibility for the delivery, development and quality assurance of study programmes
No records yet.
V.3. Responsibility for the development and quality of habilitation and inauguration fields
No records yet.
V.4. Overview of supervised theses
| Bachelor | Master | Doctoral | |
|---|---|---|---|
| Currently supervised theses | 0 | 0 | 1 |
| Defended theses | 8 | 101 | 6 |
V.5. Overview of other taught courses
| Course | Study programme | Degree | Study field |
|---|---|---|---|
Clinical pharmacy | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Over the counter drugs | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
Pharmacology I. | Pharmacy – full-time study, Slovak language | I. + II. | Pharmacy |
Clinical pharmacy | Pharmacy – full-time study, Slovak language | I. + II. | Pharmacy |
Clinical pharmacology and pharmacotherapy | Pharmacy – full-time study, Slovak language | I. + II. | Pharmacy |
Over the counter drugs | Pharmacy – full-time study, Slovak language | I. + II. | Pharmacy |
VI. Overview of research/artistic/other outputs
The last six completed calendar years: 2020–2025. The current year is excluded.
VI.1. Overview of research/artistic/other outputs and citations
| Total | Over the last six years | |
|---|---|---|
| VI.1.1 Number of research/artistic/other outputs | 945 | 187 |
| VI.1.2 Number of outputs registered in Web of Science or Scopus | 335 | 122 |
| VI.1.3 Number of citations corresponding to research/artistic/other outputs | 3909 | 2536 |
| VI.1.4 Number of citations registered in Web of Science or Scopus | 3909 | 2536 |
| VI.1.5 Number of invited lectures at international and national level | 30 | 5 |
VI.2. The most significant research/artistic/other outputs
| 1. | 2006-2010 6. Frame Programm EU- STREP 034256 Deep-Vein Thrombosis – Impedimetric Microanalysis Systém |
|---|---|
| 2. | Jan Kyselovic, Peter Krenek, Maurice Wibo, Théophile Godfraind. Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats Br J Pharmacol. 2001 IF (JCR) 2001=3,502, SCI cit.55 |
| 3. | A Samakova, A Gazova, N Sabova, S Valaskova, M Jurikova, J KyselovicThe pi3k/Akt Pathway Is Associated With Angiogenesis, Oxidative Stress and Survival of Mesenchymal Stem Cells in Pathophysiologic Condition in Ischemia. 2019 PHYSIOLOGICAL RESEARCH, 68 , pp.S131-S138, IF (JCR) 2016=2,226, SCI cit.136 |
| 4. | Feng Gao, Masaharu Kataoka, Ning Liu, Tian Liang, Zhan-Peng Huang, Fei Gu, Jian Ding, Jianming Liu, Feng Zhang, Qing Ma, Yingchao Wang, Mingming Zhang, Xiaoyun Hu, Jan Kyselovic, Xinyang Hu, William T Pu, Jian’an Wang, Jinghai Chen, Da-Zhi Wang: Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction, Nature commun 2019, 10 (1), 1802, IF (JCR) 2019=12,121, SCI cit.251 |
| 5. | Krenek P, Kmecova J, Kucerova D, Bajuszova Z, Musil P, Gazova A, Ochodnicky P, Klimas J, Kyselovic J. Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function. Eur J Heart Fail. 2009 Feb;11(2):140-6. IF (JCR) 2009=3,9 Q1, SCI cit.85 |
VI.3. The most significant research/artistic/other outputs over the last six years
| 1. | Feng Gao, Masaharu Kataoka, Ning Liu, Tian Liang, Zhan-Peng Huang, Fei Gu, Jian Ding, Jianming Liu, Feng Zhang, Qing Ma, Yingchao Wang, Mingming Zhang, Xiaoyun Hu, Jan Kyselovic, Xinyang Hu, William T Pu, Jian’an Wang, Jinghai Chen, Da-Zhi Wang: Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction, Nature commun 2019, 10 (1), 1802, IF (JCR) 2019=12,121, SCI cit.251 |
|---|---|
| 2. | Haipeng Guo, Yao Wei Lu, Zhiqiang Lin, Zhan-Peng Huang, Jianming Liu, Yi Wang, Hee Young Seok, Xiaoyun Hu, Qing Ma, Kathryn Li, Jan Kyselovic, Qingchuan Wang, Jenny L-C Lin, Jim J-C Lin, Douglas B Cowan, Francisco Naya, Yuguo Chen, William T Pu, Da-Zhi WangIntercalated disc protein Xinβ is required for Hippo-YAP signaling in the heart. Nature commun, 2020,11, 4666, IF (JCR) 2020=14,919Q1 SCI cit.16 |
| 3. | Adamičková A, Chomaničová N, Gažová A, Maďarič J, Červenák Z, Valášková S, Adamička M,K yselovic J. Effect of Atorvastatin on Angiogenesis-Related Genes VEGF-A, HGF and IGF-1 and the Modulation of PI3K/AKT/mTOR Transcripts in Bone-Marrow-Derived Mesenchymal Stem Cells. Curr Issues Mol Biol. 2023 Mar 10;45(3):2326-2337 IF (JCR) 2023=2,919Q1 SCI cit.9 |
| 4. | Kyselovic J, Adamičková A, Gažová A, Valášková S, Chomaničová N, Červenák Z, Madaric J. Atorvastatin Treatment Significantly Increased the Concentration of Bone Marrow-Derived Mononuclear Cells and Transcutaneous Oxygen Pressure and Lowered the Pain Scale after Bone Marrow Cells Treatment in Patients with "No-Option" Critical Limb Ischaemia. Biomedicines. 2024 Apr 22;12(4):922 IF (JCR) 2023=4,9 Q1 SCI cit.9 |
| 5. | Samakova A, Gazova A, Sabova N, Valaskova S, Jurikova M, Kyselovic J. The PI3k/Akt pathway is associated with angiogenesis, oxidative stress and survival of mesenchymal stem cells in pathophysiologic condition in ischemia. Physiol Res. 2019 Nov 30;68(Suppl 2):S131-S138. doi: 10.33549/physiolres.934345. PMID: 31842576. |
VI.4. The most significant citations corresponding to research/artistic/other outputs
| 1. | 2024 Udelenie titulu: Fellow of European Cardiology Society |
|---|---|
| 2. | 2025 Udelenie titulu Fellow of International Academy of Cardiovascular Society |
| 3. | Celkový počet ohlasov WoS/SCOPUS 1858/2051 |
| 4. | Collaboration: 33.3% International collaboration during the last 10 years 458 co-authors with researchers in other countries/regions |
| 5. | 24.7% (20 documents/ last 10 years) Documents in top 25% journals by CiteScore percentile VI. |
VI.5. Participation in conducting or leading the most important projects over the last six years
| 1. | BIOFORD_Systemická verejná výskumná infraštruktúra – biobanka pre rakovinu a zriedkavé choroby. EU, state budget: 313011AGF5 18 mil. EUR 2020 - 2023 Key researcher of partner of the project |
|---|---|
| 2. | USCCCORD: Zvyšovanie kapacít a kompetencií Univerzity Komenského v oblasti výskumu, vývoja a inovácií. EU, state budget: 313021BUZ3 5,8 mil. EUR 2022 - 2023 Key researcher of partner of the project |
| 3. | PROMEGA_Výskum a vývoj v lekárskych vedách - cesta k personalizovanej liečbe závažných neurologických, kardiovaskulárnych a nádorových ochorení. EU, state budget: 313011T431 13,1 mil. EUR 2016 - 2019 Principal investigator of partner of the project |
| 4. | BIOMIN_Strategický priemyselný výskum a vývoj humánnych liekov na báze kalciových biopreparátov zameraných na prevenciu a liečbu osteologických EU, state budget: 313012Q751 2,0 mil. EUR 2019 - 2022 Principal investigator of partner of the project |
| 5. | Regenerative potential of pharmacological intervetion to the GATA4, HAND2, MEF2C and TBX5 signal pathways in cell based therapy of cardiovascular diseases. State budget: APVV-14-0416 250 000€ 2015- 2019 Principal investigator |
VII. Overview of organizational experience related to higher education and research/artistic/other activities
| Position / activity | Institution | Year |
|---|---|---|
EU expert for Inovative medicine EMA | EMA , London, Great Britain | 2012 – 2018 |
Guarantor and chairman of the doctoral study department 7.1.30 Pharmacology | Faculty of Pharmacy, Comenius University in Bratislava | 2010 – 2017 |
Garant MSc study Farmacy | Faculty of Pharmacy, Comenius University in Bratislava | 2010 – 2017 |
member of Scietifical Board | Charles Univerisity Prag | 2010 – to date |
Vice-Chairman of the Doctoral Study Committee 7.1.30 Pharmacology | Faculty of Pharmacy, Comenius University Bratislava | 2005 – 2011 |
VIII. Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study
| Institution | Address | Mobility scheme, employment contract, other | Year |
|---|---|---|---|
Research Centre, Sainte Justine Hospital | Montreal, Canada | visiting scientist | 2004 – 2004 |
Dept. Pharmacology and toxicology, Catholic University of Louvain, UCL, Brusselles, Belgium Dept. Pharmacology and toxicology | Brusseles, Belgium | visiting scientist | 1996 – 2001 |
Department Pharmacology Medical Faculty | University of Ottawa, Canada | postgradual study stay MDAC in Pharmacology | 1993 – 1994 |
Department Pharmacology Medical Faculty | University of Ottawa, Canada | study stay - grant MRC of Canada | 1992 – 1992 |
IX. Other relevant facts
|
1985: Slovak Academy of Sciences Award: "Best Student Scientific Paper" 1987: Rector of Comenius University Award for excellent academic results Cum Laudum 1989-1992: Member of the Academic Senate of the Faculty of Medicine, Comenius University 1995-1996: Member of the Academic Senate of the Faculty of Pharmacy, Comenius University – Senate Secretary 2003-2009: Member of the Academic Senate of Comenius University 2006-2009: Member of the Council of Higher Education Institutions 2013: Slovak Pharmaceutical Society Award 2013: Faculty of Pharmacy, Comenius University, Hradec Králové Award 2015-2017: Member of the Men's Health EU Advisory Board 2023: Zuffa Medal, Slovak Pharmaceutical Medal 2023: Bronze Medal, Faculty of Medicine, Comenius University Bratislava 2023: Silver Medal, Slovak Medical Society |